| UniProt ID | FBX7_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y3I1 | |
| Protein Name | F-box only protein 7 | |
| Gene Name | FBXO7 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 522 | |
| Subcellular Localization | Cytoplasm. Nucleus. Mitochondrion. Cytoplasm, cytosol. Predominantly cytoplasmic. A minor proportion is detected in the nucleus. Relocates from the cytosol to depolarized mitochondria. | |
| Protein Description | Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Recognizes BIRC2 and DLGAP5. Plays a role downstream of PINK1 in the clearance of damaged mitochondria via selective autophagy (mitophagy) by targeting PRKN to dysfunctional depolarized mitochondria. Promotes MFN1 ubiquitination.. | |
| Protein Sequence | MRLRVRLLKRTWPLEVPETEPTLGHLRSHLRQSLLCTWGYSSNTRFTITLNYKDPLTGDEETLASYGIVSGDLICLILQDDIPAPNIPSSTDSEHSSLQNNEQPSLATSSNQTSMQDEQPSDSFQGQAAQSGVWNDDSMLGPSQNFEAESIQDNAHMAEGTGFYPSEPMLCSESVEGQVPHSLETLYQSADCSDANDALIVLIHLLMLESGYIPQGTEAKALSMPEKWKLSGVYKLQYMHPLCEGSSATLTCVPLGNLIVVNATLKINNEIRSVKRLQLLPESFICKEKLGENVANIYKDLQKLSRLFKDQLVYPLLAFTRQALNLPDVFGLVVLPLELKLRIFRLLDVRSVLSLSAVCRDLFTASNDPLLWRFLYLRDFRDNTVRVQDTDWKELYRKRHIQRKESPKGRFVMLLPSSTHTIPFYPNPLHPRPFPSSRLPPGIIGGEYDQRPTLPYVGDPISSLIPGPGETPSQFPPLRPRFDPVGPLPGPNPILPGRGGPNDRFPFRPSRGRPTDGRLSFM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 | Phosphorylation | RVRLLKRTWPLEVPE HHEHHHCCCCCCCCC | 29.82 | 26270265 | |
| 28 | Phosphorylation | PTLGHLRSHLRQSLL CCHHHHHHHHHHHHH | 32.98 | 29759185 | |
| 33 | Phosphorylation | LRSHLRQSLLCTWGY HHHHHHHHHHHCCCC | 19.51 | 25072903 | |
| 37 | Phosphorylation | LRQSLLCTWGYSSNT HHHHHHHCCCCCCCC | 23.15 | 25072903 | |
| 40 | Phosphorylation | SLLCTWGYSSNTRFT HHHHCCCCCCCCEEE | 10.65 | 25072903 | |
| 41 | Phosphorylation | LLCTWGYSSNTRFTI HHHCCCCCCCCEEEE | 17.11 | 25072903 | |
| 42 | Phosphorylation | LCTWGYSSNTRFTIT HHCCCCCCCCEEEEE | 33.46 | 25072903 | |
| 44 | Phosphorylation | TWGYSSNTRFTITLN CCCCCCCCEEEEEEE | 29.16 | 25072903 | |
| 113 | Ubiquitination | LATSSNQTSMQDEQP CCCCCCCCCCCCCCC | 30.34 | 29967540 | |
| 148 | Ubiquitination | GPSQNFEAESIQDNA CCCCCCCCHHHHHCC | 16.23 | 29967540 | |
| 153 | Ubiquitination | FEAESIQDNAHMAEG CCCHHHHHCCCCCCC | 53.25 | 21890473 | |
| 173 | Ubiquitination | SEPMLCSESVEGQVP CCCCCCCCCCCCCCC | 58.78 | 29967540 | |
| 175 | Ubiquitination | PMLCSESVEGQVPHS CCCCCCCCCCCCCCC | 9.34 | 29967540 | |
| 195 | Ubiquitination | QSADCSDANDALIVL HCCCCCCHHHHHHHH | 10.25 | 21890473 | |
| 208 | Ubiquitination | VLIHLLMLESGYIPQ HHHHHHHHHCCCCCC | 4.83 | 29967540 | |
| 210 | Ubiquitination | IHLLMLESGYIPQGT HHHHHHHCCCCCCCC | 32.70 | 29967540 | |
| 227 | Ubiquitination | KALSMPEKWKLSGVY HHCCCCCHHCCCCEE | 43.70 | 29967540 | |
| 230 | Ubiquitination | SMPEKWKLSGVYKLQ CCCCHHCCCCEEEEE | 5.38 | 21890473 | |
| 230 | Ubiquitination | SMPEKWKLSGVYKLQ CCCCHHCCCCEEEEE | 5.38 | 21890473 | |
| 230 | Ubiquitination | SMPEKWKLSGVYKLQ CCCCHHCCCCEEEEE | 5.38 | 21890473 | |
| 230 | Ubiquitination | SMPEKWKLSGVYKLQ CCCCHHCCCCEEEEE | 5.38 | 21890473 | |
| 237 | Ubiquitination | LSGVYKLQYMHPLCE CCCEEEEEECCCCCC | 29.38 | 21890473 | |
| 279 | Ubiquitination | RSVKRLQLLPESFIC HHCCEEEECCHHHCC | 11.59 | 21890473 | |
| 283 | Phosphorylation | RLQLLPESFICKEKL EEEECCHHHCCHHHH | 20.26 | - | |
| 286 | S-nitrosylation | LLPESFICKEKLGEN ECCHHHCCHHHHCCC | 4.36 | 19483679 | |
| 286 | S-nitrosocysteine | LLPESFICKEKLGEN ECCHHHCCHHHHCCC | 4.36 | - | |
| 287 | Ubiquitination | LPESFICKEKLGENV CCHHHCCHHHHCCCH | 53.74 | 29967540 | |
| 289 | Ubiquitination | ESFICKEKLGENVAN HHHCCHHHHCCCHHH | 47.49 | 29967540 | |
| 289 | Acetylation | ESFICKEKLGENVAN HHHCCHHHHCCCHHH | 47.49 | 25953088 | |
| 305 | Phosphorylation | YKDLQKLSRLFKDQL HHHHHHHHHHHHHHC | 33.69 | 21955146 | |
| 309 | Ubiquitination | QKLSRLFKDQLVYPL HHHHHHHHHHCHHHH | 49.51 | 21890473 | |
| 314 | Ubiquitination | LFKDQLVYPLLAFTR HHHHHCHHHHHHHHH | 9.21 | 21890473 | |
| 314 | Ubiquitination | LFKDQLVYPLLAFTR HHHHHCHHHHHHHHH | 9.21 | 21890473 | |
| 314 | Ubiquitination | LFKDQLVYPLLAFTR HHHHHCHHHHHHHHH | 9.21 | 21890473 | |
| 314 | Ubiquitination | LFKDQLVYPLLAFTR HHHHHCHHHHHHHHH | 9.21 | 21890473 | |
| 384 | Phosphorylation | LRDFRDNTVRVQDTD HHHCCCCEEEEECCC | 17.61 | - | |
| 393 | Ubiquitination | RVQDTDWKELYRKRH EEECCCHHHHHHHHH | 40.42 | 21906983 | |
| 417 | O-linked_Glycosylation | RFVMLLPSSTHTIPF CEEEECCCCCCCCCC | 48.08 | 30059200 | |
| 421 | O-linked_Glycosylation | LLPSSTHTIPFYPNP ECCCCCCCCCCCCCC | 30.36 | 30059200 | |
| 432 | Methylation | YPNPLHPRPFPSSRL CCCCCCCCCCCHHCC | 34.44 | - | |
| 451 | Methylation | IGGEYDQRPTLPYVG CCCCCCCCCCCCCCC | 24.23 | - | |
| 479 | Methylation | PSQFPPLRPRFDPVG CCCCCCCCCCCCCCC | 26.56 | - | |
| 481 | Methylation | QFPPLRPRFDPVGPL CCCCCCCCCCCCCCC | 42.01 | - | |
| 498 | Methylation | PNPILPGRGGPNDRF CCCCCCCCCCCCCCC | 44.98 | - | |
| 504 | Methylation | GRGGPNDRFPFRPSR CCCCCCCCCCCCCCC | 48.02 | - | |
| 518 | Methylation | RGRPTDGRLSFM--- CCCCCCCCCCCC--- | 29.93 | - | |
| 518 | Asymmetric dimethylarginine | RGRPTDGRLSFM--- CCCCCCCCCCCC--- | 29.93 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FBX7_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FBX7_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FBX7_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 260300 | Parkinson disease 15 (PARK15) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...